FDA Focuses Latest Warnings on Accountability and Root Cause
This article was originally published in The Gold Sheet
Executive Summary
Quest for accountability and root cause seen in latest FDA warning letters. FDA, Congress pressure McNeil, J&J. 'Phantom recall' debated. Is propofol too hard for Teva, Hospira to make? Perrigo raked over tablet mix-ups. Braintree learns to fear spiders. Merck unit goes OOS. Splitting hairs over Shamrock's tablet splitting? Pierre Fabre: Three batches and you're out?
You may also be interested in...
Perrigo Applies Crime Scene Investigation Model to Improve Quality Control
Perrigo quality control managers emphasize immediate investigations of low-risk incidents and forward-looking remediation in the firm’s new corrective and preventive actions strategy.
Perrigo Applies Crime Scene Investigation Model to Improve Quality Control
Perrigo quality control managers emphasize immediate investigations of low-risk incidents and forward-looking remediation in the firm’s new corrective and preventive actions strategy.
Another Busy Year of Drug Recalls Led to Shortages of Injectables
Manufacturers recalled more drug products from the U.S. market in 2010 than they had in any year but 2009.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: